Silke Bollen

Silke Bollen is a Global Director of Oncology Marketing at Amgen, where they drive the launch of LUMAKRAS for NSCLC across multiple markets. Previously, from 2016 to 2018, Silke held several roles at Amgen, including EU Senior Manager Marketing Oncology, leading initiatives for solid tumors, and Global Director Service Center, managing a team focused on commercial and medical asset production. Silke started their professional journey as a pharmacist at Apotheek Herbrand and Apotheek Bormans before gaining experience at MSD as a consultant. Silke holds a Master's in drug development and a Bachelor's and Master's in Pharmaceutical Sciences from Katholieke Universiteit Leuven, both awarded magna cum laude. Additionally, they completed a PhD in gene therapy and oncology at KULeuven, along with a course in disruptive strategy at Harvard Business School.